• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Estimation of treatment effect in presence of noncompliance and competing risks: a simulation study.存在不依从和竞争风险时的治疗效果估计:一项模拟研究。
Sci Rep. 2023 Aug 18;13(1):13477. doi: 10.1038/s41598-023-40538-2.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Correcting treatment effect for treatment switching in randomized oncology trials with a modified iterative parametric estimation method.使用改良的迭代参数估计方法校正随机肿瘤试验中治疗转换的治疗效果。
Stat Med. 2016 Sep 20;35(21):3690-703. doi: 10.1002/sim.6923. Epub 2016 Feb 25.
4
Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.评估临床试验中处理治疗转换的方法:一项后续模拟研究。
Stat Methods Med Res. 2018 Mar;27(3):765-784. doi: 10.1177/0962280216642264. Epub 2016 Apr 25.
5
Performance of statistical methods for analysing survival data in the presence of non-random compliance.存在非随机依从性时分析生存数据的统计方法的性能。
Stat Med. 2010 Dec 20;29(29):2994-3003. doi: 10.1002/sim.4070. Epub 2010 Oct 20.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.在存在竞争风险的情况下评估健康结局:统计方法和临床应用的综述。
Med Care. 2010 Jun;48(6 Suppl):S96-105. doi: 10.1097/MLR.0b013e3181d99107.
8
Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study.调整肺动脉高压治疗转换后马昔腾坦的总生存估计:SERAPHIN 研究结果。
Adv Ther. 2022 Sep;39(9):4346-4358. doi: 10.1007/s12325-022-02253-8. Epub 2022 Aug 1.
9
Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.在存在不依从性的随机试验中评估安全性上限的因果推断方法。
Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1.
10
Cross-sectional analysis characterizing the use of rank preserving structural failure time in oncology studies: changes to hazard ratio and frequency of inappropriate use.跨截面分析,对肿瘤学研究中使用秩保持结构失效时间的特点进行描述:危害比和不适当使用频率的变化。
Trials. 2023 Jun 3;24(1):373. doi: 10.1186/s13063-023-07412-y.

引用本文的文献

1
Further Practical Guidance on Adjusting Time-To-Event Outcomes for Treatment Switching.关于调整治疗转换的事件发生时间结局的进一步实用指南。
Pharm Stat. 2025 Jul-Aug;24(4):e70019. doi: 10.1002/pst.70019.

本文引用的文献

1
Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding.改进的两阶段估计法以调整随机试验中的治疗转换:用于解决时间依存性混杂的g估计法。
Stat Methods Med Res. 2020 Oct;29(10):2900-2918. doi: 10.1177/0962280220912524. Epub 2020 Mar 30.
2
Competing risks in survival data analysis. 生存数据分析中的竞争风险。
Radiother Oncol. 2019 Jan;130:185-189. doi: 10.1016/j.radonc.2018.09.007. Epub 2018 Oct 9.
3
Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?在存在治疗转换的随机试验中对长期生存的因果推断:在估计反事实生存时间时是否应该重新删失?
Stat Methods Med Res. 2019 Aug;28(8):2475-2493. doi: 10.1177/0962280218780856. Epub 2018 Jun 25.
4
On an enhanced rank-preserving structural failure time model to handle treatment switch, crossover, and dropout.关于一种用于处理治疗转换、交叉和失访的增强型秩保持结构失效时间模型。
Stat Med. 2017 May 10;36(10):1532-1547. doi: 10.1002/sim.7224. Epub 2017 Jan 22.
5
Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.评估临床试验中处理治疗转换的方法:一项后续模拟研究。
Stat Methods Med Res. 2018 Mar;27(3):765-784. doi: 10.1177/0962280216642264. Epub 2016 Apr 25.
6
Correcting treatment effect for treatment switching in randomized oncology trials with a modified iterative parametric estimation method.使用改良的迭代参数估计方法校正随机肿瘤试验中治疗转换的治疗效果。
Stat Med. 2016 Sep 20;35(21):3690-703. doi: 10.1002/sim.6923. Epub 2016 Feb 25.
7
Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models.使用结构模型对具有活性对照和安慰剂对照的随机非劣效性试验中的不依从性进行校正。
Stat Med. 2015 Mar 15;34(6):950-65. doi: 10.1002/sim.6392. Epub 2014 Dec 23.
8
Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method.随机对照试验中治疗转换的调整——一项模拟研究及一种简化的两阶段方法
Stat Methods Med Res. 2017 Apr;26(2):724-751. doi: 10.1177/0962280214557578. Epub 2014 Nov 21.
9
Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study.在存在不依从性的随机对照试验中估计治疗效果:一项模拟研究。
BMJ Open. 2014 Jun 17;4(6):e005362. doi: 10.1136/bmjopen-2014-005362.
10
Applying competing risks regression models: an overview.应用竞争风险回归模型:概述
Lifetime Data Anal. 2013 Jan;19(1):33-58. doi: 10.1007/s10985-012-9230-8. Epub 2012 Sep 26.

存在不依从和竞争风险时的治疗效果估计:一项模拟研究。

Estimation of treatment effect in presence of noncompliance and competing risks: a simulation study.

机构信息

Department of Biostatistics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.

Staburo GmbH, Munich, Germany.

出版信息

Sci Rep. 2023 Aug 18;13(1):13477. doi: 10.1038/s41598-023-40538-2.

DOI:10.1038/s41598-023-40538-2
PMID:37596461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10439130/
Abstract

A randomized controlled trial is commonly designed to assess the treatment effect in survival studies, in which patients are randomly assigned to the standard or the experimental treatment group. Upon disease progression, patients who have been randomized to standard treatment are allowed to switch to the experimental treatment. Treatment switching in a randomized controlled trial refers to a situation in which patients switch from their randomized treatment to another treatment. Often, the switchis from the control group to the experimental treatment. In this case, the treatment effect estimate is adjusted using either convenient naive methods such as intention-to-treat, per-protocol or advanced methods such as rank preserving structural failure time (RPSFT) models. In previous simulation studies performed so far, there was only one possible outcome for patients. However, in oncology in particular, multiple outcomes are potentially possible. These outcomes are called competing risks. This aspect has not been considered in previous studies when determining the effect of a treatment in the presence of noncompliance. This study aimed to extend the RPSFT method using a two-dimensional G-estimation in the presence of competing risks. The RPSFT method was extended for two events, the event of interest and the competing event. For this purpose, the RPSFT method was applied based on the cause-specific hazard approach, the result of which is compared to the naive methods used in simulation studies. The results show that the proposed method has a good performance compared to other methods.

摘要

一项随机对照试验通常用于评估生存研究中的治疗效果,在该研究中,患者被随机分配到标准治疗组或实验治疗组。在疾病进展后,随机分配到标准治疗的患者可以被允许转为实验治疗。随机对照试验中的治疗转换是指患者从随机治疗转为另一种治疗的情况。通常,这种转换是从对照组到实验组。在这种情况下,治疗效果估计是通过方便的朴素方法(如意向治疗、方案治疗或高级方法如等级保持结构失效时间(RPSFT)模型)进行调整。在迄今为止进行的模拟研究中,患者只有一种可能的结果。然而,在肿瘤学中,特别是,可能有多种结果。这些结果被称为竞争风险。在考虑到不依从性的情况下,这方面在以前的研究中并没有被考虑到。本研究旨在扩展存在竞争风险时使用二维 G 估计的 RPSFT 方法。RPSFT 方法扩展到两个事件,即感兴趣的事件和竞争事件。为此,基于特定原因的危险方法应用 RPSFT 方法,其结果与模拟研究中使用的朴素方法进行比较。结果表明,与其他方法相比,所提出的方法具有良好的性能。